Clinical trials
Completed Schizophrenia trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 66 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen-Cilag International NV | 6 |
| Dr. Lutfi Kirdar Kartal Training and Research Hospital | 5 |
| Hoffmann-La Roche | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
| Yeditepe University | 3 |
| Dokuz Eylul University | 2 |
| Eli Lilly and Company | 2 |
| Gazi University | 2 |
| Hacettepe University | 2 |
| Istanbul University - Cerrahpasa | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 66 |
| Psychotic Disorders | 5 |
| Bipolar Disorder | 3 |
| Mental Disorders | 2 |
| Apraxias | 1 |
| Cognitive Dysfunction | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Metabolic Syndrome | 1 |
| Nerve Degeneration | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.